Literature DB >> 24602945

Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.

Ashish Bhargava1, Kayoko Hayakawa, Ethan Silverman, Samran Haider, Krishna Chaitanya Alluri, Satya Datla, Sreelatha Diviti, Vamsi Kuchipudi, Kalyan Srinivas Muppavarapu, Paul R Lephart, Dror Marchaim, Keith S Kaye.   

Abstract

BACKGROUND: This study aimed to identify risk factors associated with carbapenem-resistant Enterobacteriaceae (CRE) colonization among patients screened with rectal cultures upon admission to a hospital or long-term acute care (LTAC) center and to compare risk factors among patients who were screen positive for CRE at the time of hospital admission with those screen positive prior to LTAC admission.
METHODS: A retrospective nested matched case-control study was conducted from June 2009 to December 2011. Patients with recent LTAC exposure were screened for CRE carriage at the time of hospital admission, and patients admitted to a regional LTAC facility were screened prior to LTAC admission. Cases were patients with a positive CRE screening culture, and controls (matched in a 3∶1 ratio to cases) were patients with negative screening cultures.
RESULTS: Nine hundred five cultures were performed on 679 patients. Forty-eight (7.1%) cases were matched to 144 controls. One hundred fifty-eight patients were screened upon hospital admission and 521 prior to LTAC admission. Independent predictors for CRE colonization included Charlson's score greater than 3 (odds ratio [OR], 4.85 [95% confidence interval (CI), 1.64-14.41]), immunosuppression (OR, 3.92 [95% CI, 1.08-1.28]), presence of indwelling devices (OR, 5.21 [95% CI, 1.09-2.96]), and prior antimicrobial exposures (OR, 3.89 [95% CI, 0.71-21.47]). Risk factors among patients screened upon hospital admission were similar to the entire cohort. Among patients screened prior to LTAC admission, the characteristics of the CRE-colonized and noncolonized patients were similar.
CONCLUSIONS: These results can be used to identify patients at increased risk for CRE colonization and to help target active surveillance programs in healthcare settings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24602945     DOI: 10.1086/675614

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  34 in total

1.  Frequency of and risk factors for carbapenem-resistant Enterobacteriaceae.

Authors:  Katie E Barber; Jamie L Wagner; Rachel C Larry; Kayla R Stover
Journal:  J Med Microbiol       Date:  2021-02       Impact factor: 2.472

Review 2.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

3.  Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Authors:  Sarah M Bartsch; Susan S Huang; Kim F Wong; Rachel B Slayton; James A McKinnell; Daniel F Sahm; Krystyna Kazmierczak; Leslie E Mueller; John A Jernigan; Bruce Y Lee
Journal:  J Clin Microbiol       Date:  2016-08-31       Impact factor: 5.948

4.  Outbreak Column 15: Carbapenemase-producing Enterobacteriaceae.

Authors:  Evonne T Curran; Jonathan A Otter
Journal:  J Infect Prev       Date:  2014-09

5.  Act Fast as Time Is Less: High Faecal Carriage of Carbapenem-Resistant Enterobacteriaceae in Critical Care Patients.

Authors:  Sanjith Saseedharan; Manisa Sahu; Edwin Joseph Pathrose; Sarita Shivdas
Journal:  J Clin Diagn Res       Date:  2016-09-01

Review 6.  Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Authors:  Sandra S Richter; Dror Marchaim
Journal:  Virulence       Date:  2016-11-04       Impact factor: 5.882

7.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

8.  The growing threat of carbapenem resistant enterobacteriaceae (CRE) within in-patient spinal rehabilitation units.

Authors:  Priyadarshini Chari; Anna Seruga; Nelson Nathan; David M Bowers
Journal:  Spinal Cord Ser Cases       Date:  2016-07-07

9.  Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in brain and spinal cord injury patients: potential for prolonged colonization.

Authors:  N R Zembower; A Zhu; M Malczynski; C Qi
Journal:  Spinal Cord       Date:  2016-10-18       Impact factor: 2.772

Review 10.  Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned.

Authors:  David van Duin; David L Paterson
Journal:  Infect Dis Clin North Am       Date:  2016-06       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.